Menu ×


Molecular Transport Medium Market Analysis by Type (Viral Transportation Medium, and Virus Swabs); by Application (Diagnostic Laboratories, Microbiology Laboratories, Hospitals & Clinics, and Others); and by Indication (Mumps Virus, Influenza, Rhinovirus, Adenovirus, COVID-19, and Other) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • June 7,2022: Thermo Fisher Scientific is offering in vitro diagnostic requirements (IVDR) versions to help molecular diagnostic manufacturers to adopt higher standards.
  • May 26,2022: Becton, Dickinson, and Company (BD)introduced a new high throughput molecular diagnostic combination test for SARS-CoV-2 and Influenza A/B, the second test for BD COR to have been CE marked to the IVD directive.

Global Molecular Transport Medium Market Highlights Over 2022 - 2031


The global molecular transport mediummarket is estimated to garner significantrevenue by the end of 2031 by growing at a CAGR of ~4% over the forecast period, i.e., 2022 – 2031. Further, the market generated modest revenue in the year 2021. For instance, the rising number of experiments at labs and research institutions is attributed to the growth of the market. The percentage of research and development expenditure (in % GDP) is 2.63% in 2020, up from 2.13% in 2017.


Get more information on this report: Request Sample PDF

Further, the growing adoption of transport mediums for infectious disorders and rising awareness regarding the early detection of viral diseases have compelled governments to initiate management measures to prevent outbreaks of these infections.The U.S. funding for global health security for the fiscal year 2021 was raised to USD 670 raised from USD 397 in 2011.Also, additional funding was provided for the emergency outbreaks of Ebola and the Zika virus.

Global Molecular Transport MediumMarket: Growth Drivers and Challenges

Growth Drivers

  • Rise in the Number of Infectious Diseases Like Influenza

According to WHO, the number of infectious and parasitic diseases touched 7.2 million in 2018.

  • An Increasing Number of Diagnostic Tests

More than 3 billion in vitro diagnostic tests wereconducted every year (both FDA-reviewed and lab-developed tests) across the globe.

  • Rise In Experiments in Laboratories and Research Institutes

According to the data by the World Bank, there were 1597 researchers involved in research and development activities per 1,000,000 people, as of 2018, up from 1412 per million in 2015.

  • Rising Awareness for the Health of Co-Workers in a Laboratory

Total fatal occupational injuries in healthcare practitioners and technical occupations decreased from 60 in 2016 to 51 in 2020, and healthcare support occupations raised from 30 in 2016 to 44 in 2020.

  • Growing Expenditure for R&D Activities

Globally, 2.63% of the GDP was spent for research and development in 2020.


  • Uncertain Nature of Occurrence of Infections Leading to the Adoption of a Conservative Approach
  • Unpredictable Nature of Seasonal Infections
  • High Risk of False Results by Molecular Medium

The market is segmented and analyzed for demand and supply by type into viral transportation medium, and virus swabs, out of these,the viral transportation medium segment holdssignificantgrowth during the forecast period.Moreover, the sudden incidence of the COVID-19 pandemic increased the demand for transport medium products and kits. According to the Journal of Clinical Microbiologybetween 3000tomore than 5000 viral transport medium tubes are produced each day to support SARS-CoV-2 PCR testing.The innovation of kits containing vials, double-ended flocked swabs, antibiotics, and other antibacterial and antifungal items that prevent contamination is estimated to drive the segment growth.

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5,355.79, which grew from USD 3,515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Molecular Transport MediumMarket Regional Synopsis

Regionally, the globalmolecular transport mediummarket is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North Americaregion is projected to hold the largest market share by the end of 2031on account ofenhancement in the availability of new diagnostic test kits and drugs in pharmacies and retail shops as OTC drugs.As of December 2021, 300 million at-home rapid test kits are available in the market in the U.S., with a 10-fold increase from 24 million in August 2021.

The rise in the number of infections, parasitic diseases, and an increase in the manufacturing capacity of vaccines and drugs is estimated to boost the market growth during the forecast period.COVID-19 vaccine manufacturing productivityreacheda mark of7.5 million doses with the production of 1.5 billion doses per month by vaccine manufacturers across the world. Ellume which was issued as an emergency COVID-19 treatment on 15 December 2020, was authorized for revisionby FDA to Emergency Use Authorization (EUA) on February 11, 2021. The recall was done to reduce the false positive test results, unnecessary quarantine, and treatment with antivirals.


The global molecular transport mediummarket is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global molecular transport mediummarket includes the following segments:

By Type

  • Viral Transportation Medium
  • Virus Swabs

By Application

  • Diagnostic Laboratories
  • Microbiology Laboratories
  • Hospitals and Clinics
  • Others

By Indication

  • Mumps Virus
  • Influenza
  • Rhinovirus
  • Adenovirus
  • COVID-19
  • Others


Top Featured Companies Dominating the Global Molecular Transport Medium Market

  • Thermo Fisher Scientific Holdings, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Becton, Dickinson and Company
  • Medical Wire & Equipment
  • COPAN Diagnostics Inc
  • Titan Biotech
  • EKF Diagnostics Holdings plc
  • Trinity Biotech Plc
  • Puritan Medical Products LLC
  • Longhorn Vaccines&Diagnostics LLC
  • Mylab Discovery SolutionsPvt. Ltd.
  • 2BScientific Limited


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved